Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herbal Tea for Glycemic Control in Early T2DM
NCT03787563Unknown
- Sponsor
- Composite Interceptive Med-Science Laboratories
- Start
- Jan 2019
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoints: Fasting Plasma Glucose at 5 days, Oral Glucose Tolerance Test at 5 days and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT03787563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787563.